Ref ID: 18420
Author:
Lilian Junker , Jörg Halter, Alexis Dumoulin, Daiana Stolz, Dominik Heim,
Martin Stern , Christoph Bucher, Jakob Passweg, Hans Hirsch,
Michael Tamm.
Author address:
Clinic of Pulmonary Medicine and Respiratory Cell Research,
University Hospital Basel, Basel, Switzerland;Clinic of Hematology, University Hospital Basel, Basel, Switzerland; Institute for Microbiology, University
Hospital Basel, Basel, Switzerland
Full conference title:
European Respiratory Congress
Abstract:
Pulmonary complications are frequent in hematologic patients. Regular investigation
of BAL fluid includes bacterial/fungal culture, staining and PCR for
mycobacteria, immunohistochemistry/Grocott staining for pneumocystis and cell
differentiation. The increasing use of PCR allows to search for different viruses.
In this study we analysed the diagnostic yield of a recently established multi
PCR for detection of 13 viruses. 219 hematologic patients underwent diagnostic
bronchoscopy with BAL from september 2009 to january 2011. 28 of patients
received high dose chemotherapy, 143 underwent allogeneic and 13 autologous
stemcell transplantation. Bacteria were cultured from 43 (20%) BALs: staphyloccocus
aureus, pseudomonas aeruginosa, streptococcus pneumoniae, enterococcus,
moraxella, enterobacteriaceae, klebsiella, corynebacterium, mycoplasma pneumoniae,
mycoplasma hominis, chlamydia pneumoniae, bordetella pertussis. There
were 7 cases of pneumocystis. In two patients we found mycobacterium gordonae.
Aspergillus was cultured in 4 cases. In 81 (37%) patients viruses were documented.
Most often we found rhinovirus (n=31; 14%), followed by CMV (n=18;
8%), HSV (n=13; 6%), RSV (n=10; 4.5%), coronavirus (n=8; 3.6%), adenovirus
(n= 7; 3.2%), parainfluenza- and metapneumovirus (each n=5; 2.2%), H1N1 (n=4;
1.8%), influenza (n=3; 1.4%), and HHV6 (n=1; 0.4%).
Summary and conclusion: The incidence of viral infections is very high in patients
with hematologic diseases and pulmonary symptoms. Multiplex PCR in the
BAL should be introduced as a routine diagnostic procedure in this specific patient
group allowing to withdraw or avoid antibiotic or antifungal therapy in many cases.
Abstract Number: P3491
Conference Year: 2011
Link to conference website: http://www.ers-education.org/ersMade/abstract_print_11/files/Abstract_book_2011.pdf
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a